MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Technology Scientific & Technical Instruments

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc

Bullboard Posts

Comment by Barrheadon May 03, 2020 11:19am

146 Views

Post# 30980967

RE:Mr.HODL

The Roche test compared to MedMira onsite and or remote use test is like comparing ice hockey in Edmonton to a dart game in a British pub. Roche is foreign Swiss Pharma needing extensive equipment and a lot longer to achieve results, and MedMira is Canadian based and simplistic that a Grade 6 kid can do at home or a remote work camp in Northern Alberta. IMO Roche isn't even in the same league, so go pedel Roche on another Forum. IMO MedMIra shareholders are going to make a bundle of cash on this one, maybe even a 5-10 bagger. Are you in or out?

Regardzzz...........Barrhead

Bullboard Posts

A potential breakthrough in spinal cord and optic nerve injury treatment